Archives

by in
Entry Author Date Location
New Study Shows How ZMapp Binds to Ebola, Ways to Boost Potency 11/17/14 San Diego
SBIR Award, $1M Investment Get ONL Therapeutics to Clinical Trials 11/12/14 Detroit
Sage’s Drug For Rare Epilepsy Shows Promise in Small Study 11/10/14 Boston
Beg, Borrow, or Steal: Accessing Unaffordable Science Journals 11/10/14 National
Struggling Aegerion Diversifies With Fat Disease Drug 11/06/14 Boston
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug 10/29/14 Boston
More Drama for Sarepta as FDA Delays Duchenne Drug, Shares Tank 10/27/14 Boston
Neothetics Files $63M IPO to Advance Drug That Melts “Love Handles” 10/22/14 San Diego
Actavis Nabs Option to Buy Rhythm Pharma’s GI Drug For Diabetics 10/22/14 Boston
San Diego’s Third-Quarter Venture Activity on Par, and Top 10 Deals 10/20/14 San Diego
VC Funding Still Robust as Year-to-Date Total Exceeds 2013 10/17/14 National
Venture Firms Turn Down Funding Volume, but Still Rockin’ in Q3 10/14/14 National
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug 10/06/14 Texas
San Diego Life Sciences Roundup: Ambit, Zogenix, Aethlon, and More 10/03/14 San Diego
Daiichi Sankyo Offers $315M Up Front to Get Ambit and Leukemia Drug 09/29/14 San Diego
Blessed By Angels, GliaCure Tests New Alzheimer’s Approach In Humans 09/26/14 Boston
San Diego Meets the Xconomists: A Real-World Innovation Commons 09/22/14 San Diego
Avalon-GSK Collaboration Generates Two More Startups in San Diego 09/22/14 San Diego
Halozyme Gets Key Validation of Enzyme Tech in HyQvia Approval 09/17/14 San Diego
MyoKardia, Sanofi Ink $200M+ Deal for Targeted Heart Drugs 09/17/14 San Francisco
Colorado Tech Roundup: Ball’s Space Lasers, Zayo to Wire the NBA 09/12/14 Boulder/Denver
At U-M, 40 Years Of Gaucher Research Rewarded With FDA Approval 09/11/14 Detroit
After Prolonged Review, FDA Approves Orexigen’s Weight-Loss Drug 09/10/14 San Diego
Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug 09/04/14 New York
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug 09/03/14 Boston
Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola 09/02/14 San Diego
Bristol-Myers Kicks Arthritis Drug Back to Alder, Shares Tumble 09/02/14 Seattle
Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed 09/02/14 San Francisco
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
Page 2 of 80 « previous page · next page »